Procedure

2015 discharge: European Medicines Agency (EMA)

2016/2169(DEC)·8th term·CONT / ENVI·DEC - Discharge procedure·CompletedProcedure completed
Subjects: 2015 discharge
Rapporteur (the Member appointed to lead Parliament's work on this text): AYALA SENDER Inés (S&D)
Summary

The dossier concerns the 2015 discharge for the European Medicines Agency. Amendments propose granting or postponing discharge and closure of the accounts, address payment deadlines to national competent authorities, conflicts of interest, revolving doors and experts' links to the pharmaceutical industry, funding from applicants' fees, whistleblower protection, recommended medicines and new active substances, the 'adaptive pathways' pilot, pharmacovigilance, and budgetary risks linked to Brexit and the UK premises.

Procedure timeline

  1. Committee amendments tabled
    14 Dec 2016 – 6 Mar 2017
  2. Procedure completed
46
Amendments
distinct, in window
18
Members
tabled at least one
2
Committee(s)
14 Dec 2016 – 6 Mar 2017
Dates

Official amendment documents